FARRELL PETER C 4

What Happened
Peter C. Farrell, a director of ResMed Inc. (RMD), sold 2,000 shares on 2026-04-01 at $225.00 per share, resulting in proceeds of $450,000. The filing reports the transaction as a disposition (sale), which is generally viewed as routine insider selling rather than a bullish signal.

Key Details

• Transaction date: 2026-04-01; Form 4 filed: 2026-04-02 (filed the next day).
• Trade: Open market sale of 2,000 shares at $225.00 per share; total proceeds $450,000.
• Shares owned after transaction: Not specified in the provided filing data.
• Footnote: Transaction was executed under a Rule 10b5-1 trading plan adopted August 12, 2025.
• Filing timeliness: Appears timely (filed the next day); no late-filing indication in the provided record.

Context
A 10b5-1 plan indicates the sale was prearranged and scheduled in advance, which often reduces concerns about trading on inside information. For retail investors, purchases tend to be more informative about insider confidence; routine sales under 10b5-1 plans are common and not necessarily a sign of negative company prospects.